# Treating Clear Cell Renal Carcinoma with Laser - Link: https://sifsof.com/clinical-apps/treating-clear-cell-renal-carcinoma-with-laser/ - Published: 2022-04-01T10:08:27+00:00 - Author: Monica A person with clear cell renal cell carcinoma (ccRCC) has kidney cancer in the tubules that filter waste from the blood. The cancer cells look like clear bubbles under a microscope. ccRCC is the most common kidney cancer. Most kidney cancers like clear cell renal cell carcinoma develop for no known reason. But certain factors may increase your risk, such as: * Smoking. * Obesity. * High blood pressure (hypertension). * Kidney disease that requires dialysis. * Exposure to workplace toxins like trichloroethylene, a solvent. * Prolonged use of pain relievers like acetaminophen Surprisingly, clear cell renal cell carcinoma usually won’t cause noticeable symptoms in its early stage. As the disease progresses, patients may experience: * Blood in urine (hematuria). * Fatigue. * Fever. * Lump, flank pain or both on the side of the diseased kidney. * Unexplained weight loss. One of the most commonly followed treatments regarding this issue is laser therapy. In fact, great success has been reported for laser treatment of squamous cell carcinoma. In this case, laser rays are obviously used to destroy cancer cells. Still, it is important to note that the perfect execution of such a task necessitates a proper and highly professional laser machine. In this vein, the[ Portable Surgery Laser System FDA SIFLASER-1.2A](https://sifsof.com/product/810-nm-portable-surgery-laser-system-fda-siflaser-1-2a/) presents itself as one of the most recommended devices among cancer surgeons viewing its high efficacy in treating skin cancers in particular. To explain in more detail, this device’s blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm (the high-level laser radiation needed), the machine performs better and gentler cutting, even at lower power. Accordingly, its improved cutting performance makes it ideally suited to all surgical applications, particularly for kidney cancer. What also makes the SIFLASER-1.2A highly appreciated and recommended by surgeons is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam. To further improve the treatment, the device is supported with a fibre guide laser. So, it is compatible with various endoscopic uses. Also, these special fibres are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area. With 980 nm wavelength and 15W as maximum power, the device is thought to perfectly address the Clear cell carcinoma issue. That is highly attributed to the fact that the SIFLASER-1.2 A uses infrared wavelengths and ultra-blue light to ensure high- level performance. That is also seen to reduce thermal damage and its peculiar interaction with haemoglobin. Due to all these features, the SIFLASER-1.2 A guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers. Studies estimate that the 5-year survival rate of CCS is between 30% and 67%. The prognosis for CCS is poor because it often spreads quickly to other parts of the body and often comes back after treatment. This necessitates regular check-ups and constant treatment. Fortunately, laser treatment has recently proved to be effective enough in terms of early diagnosing and treating this particular issue especially since it proved to be a successful addition to cancer surgery in general. In this light, we discussed the benefits of laser therapy and precisely the efficacy of SIFLASER-1.2 A as a surgical laser device capable of efficiently treating the Clear cell carcinoma issue. Reference:[ Clear Cell Renal Cell Carcinoma](https://my.clevelandclinic.org/health/diseases/22273-clear-cell-renal-cell-carcinoma) * ![Portable-surgery-diode-laser-system FDA SIFLASER-2.1A](https://sifsof.com/wp- content/uploads/2022/02/Portable-surgery-diode-laser-system-FDA-SIFLASER-2.1B- 300x300.jpg) * 810 nm Portable Surgery Laser System FDA SIFLASER-1.2A Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFSOF is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser system. The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.